G Medical Innovations Holdings Ltd. is looking to raise up to $17.3 million in an IPO of its American depositary shares.
The mobile and e-health company applied to list its ADSs on the Nasdaq Capital Market under the GMVD symbol.
G Medical noted that its shares will remain listed on the Australian Securities Exchange and will be dual listed on Nasdaq following U.S. IPO completion.
H.C. Wainwright & Co. LLC is acting as underwriter and sole running manager in the U.S. offering.
Cayman Islands-based G Medical is an early-stage commercial healthcare company that develops mobile and e-health solutions as well as monitoring platforms for patients with cardiovascular disease, pulmonary disease and diabetes.